Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1674 of 5804
-
Heat zaps seizures: new hope for kids with Drug-Resistant epilepsy
Symptom relief CompletedWhen focal epilepsies become drug-resistant, it could be eligible for cortical surgical resection. Therefore, an invasive EEG monitoring with depth electrodes is often needed during presurgical evaluation. Some of these children can have access to thermocoagulation inside the ict…
Phase: NA • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancer
Disease control OngoingThis research study is evaluating a combination of two drugs, ibrutinib and obinutuzumab, as a possible treatment for Chronic Lymphocytic Leukemia (CLL).
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Poop pills for kids? new study tests fecal transplants against stubborn gut infections
Disease control ENROLLING_BY_INVITATIONFecal Microbiota Transplant (FMT) in pediatric patients with recurrent C. Difficile with or without Inflammatory Bowel Disease (IBD) The aims of this study are to determine the safety and efficacy of FMT treatment in pediatric patients with recurrent or moderate to severe C. Dif…
Phase: PHASE1 • Sponsor: Judith Kelsen • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Balloon over stent? new study tests Drug-Coated option for heart disease
Disease control CompletedDrug-Coated Balloon (DCB) angioplasty is similar to plain old balloon angioplasty procedurally, but there is an anti-proliferative medication paclitaxel coated on the balloon. Treating in-stent restenosis (ISR) with the DCB has the theoretical advantage of avoiding multiple stent…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New back surgery study shows promise for disc disease patients
Disease control CompletedThe purpose of this study is * to evaluate the effectiveness of MAST techniques for anterior/lateral and posterior approaches in Degenerative Disc Disease (DDD) patients with spondylolisthesis (≥ grade I). * To assess how single or double level MAST(Minimal Access Spinal Technol…
Sponsor: Medtronic Spinal and Biologics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo shows promise for Hard-to-Treat sarcomas
Disease control CompletedAssessment of the efficacy and safety of trabectedin and metronomic cyclophosphamide (CP) in patients with advanced pretreated soft-tissue sarcomas, once the Maximum Tolerated Dose (MTD) have been determined (phase I trial).
Phase: PHASE1, PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a lower warfarin dose make aortic valve replacement safer?
Disease control OngoingThe purpose of the proposed study is to assess the occurrence of bleeding, valve-related thromboembolism and valve thrombosis with the On-X Aortic Prosthetic Heart Valve when targeted at an International Normalized Ratio (INR) level of 1.8 (1.5-2.0 range) during a 5-year follow-u…
Sponsor: On-X Life Technologies, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Shocking nerves back to life: new hope for amputees
Symptom relief Recruiting nowThe purpose of this study is to evaluate the effectiveness of providing sensation of the missing limb to individuals with lower limb loss, including above and below knee amputees. The approach involves delivering small electrical currents directly to remaining nerves via implante…
Phase: NA • Sponsor: Louis Stokes VA Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
New proton therapy aims to save eyes from removal in large melanoma cases
Disease control TerminatedOcular melanomas have been treated for a long time by enucleation, with an unfavorable major impact on the patient's quality of life, social life, self-image, how they feel about others and about living with this disability. As a matter of fact, classical radiation therapy by pho…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New artificial disc could replace fusion for neck pain
Disease control CompletedThis study is intended to demonstrate that the Simplify® Disc is at least as safe and effective as conventional anterior cervical discectomy and fusion (ACDF) when used to treat one level between C3 to C7 for cervical degenerative disc disease (DDD) defined as intractable radicul…
Phase: NA • Sponsor: NuVasive • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Sharper radiation boost aims to tackle head and neck cancers that return
Disease control OngoingThis research study seeks to gain new knowledge about the addition of a carefully targeted "boost" dose of radiation as a possible treatment for recurrent or metastatic head or neck cancer. The name of the study intervention involved in this study is stereotactic body radiotherap…
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Less invasive staging for endometrial cancer put to the test
Knowledge-focused OngoingThe aim of this trial is to evaluate the sentinel node policy in early stage endometrial carcinomas at intermediate and high risk of recurrence (by comparing the sentinel node policy to current initial staging protocols).
Phase: PHASE3 • Sponsor: Centre Oscar Lambret • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
New implant could keep dialysis lifelines open longer
Disease control CompletedThe objective of this study is to evaluate efficacy and safety outcomes following use of the Sirolimus-eluting Collagen Implant (SeCI) in subjects undergoing surgical creation of an AV fistula for vascular access (index procedure).
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Could a Heart-Lung drug help kids with pulmonary hypertension?
Disease control OngoingThis study was designed to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of riociguat at age-, sex- and body-weight-adjusted doses of 0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID in children from ≥6 to less than 18 years with pulmonary arterial hyperte…
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Daily painkillers may shield spines in arthritis patients on biologics
Disease control CompletedAnkylosing spondylitis (AS) is a frequent chronic inflammatory rheumatic disease that affects the axial skeleton, starting in the sacroiliac joints and spreading to the spine in most patients. Non-steroidal anti-inflammatory drugs (NSAIDs) are the primary treatment for AS. Even i…
Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New immunotherapy combo tested for incurable cancers
Disease control OngoingThe purpose of this study is to find the highest dose of durvalumab or of durvalumab with tremelimumab that can be tolerated without causing very severe side effects when receiving standard chemotherapy and to see what effects the study drugs has on this type of cancer. Patients …
Phase: PHASE1 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Experimental combo targets tough lung cancer
Disease control CompletedThe purpose of this study is to find out what effects (good and bad) AZD1775 used in combination with carboplatin and paclitaxel will have on participants and their cancer.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can a biomarker predict who responds to a new AML combo?
Disease control CompletedThis pilot phase II trial studies whether biomarkers (biological molecules) in bone marrow samples can predict treatment response to sirolimus and chemotherapy (mitoxantrone hydrochloride, etoposide, and cytarabine \[MEC\]) in patients with acute myeloid leukemia (AML) that is li…
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple mask help cancer patients avoid a breathing tube?
Disease control Recruiting nowThis randomized clinical trial studies how well non-invasive ventilation works in reducing the need for intubation, or placement of a tube in the windpipe, in patients with cancer and respiratory failure. Respiratory failure is a condition in which not enough oxygen passes from t…
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Could a higher stem cell dose beat back lymphoma?
Disease control OngoingThe purpose of this study is to study the impact of stem cell dose on outcome after autologous transplant.
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC